Literature DB >> 24021538

Neuroinflammatory phenotypes and their roles in Alzheimer's disease.

Donna M Wilcock1.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is characterized pathologically by the presence of amyloid plaques and neurofibrillary tangles in the brain. While once considered immunologically privileged due to the blood-brain barrier, it is now understood that the glial cells of the brain are capable of complex inflammatory responses.
OBJECTIVE: The goal of the study is to assess the neuroinflammatory state of the early and late AD brain using the macrophage categorizations of M1, M2a, M2b and M2c.
METHODS: We used quantitative real-time RT-PCR to assess a number of inflammatory markers in the frontal cortex and cerebellar tissue from early and late AD patients. We then used neuropathological and clinical outcomes to determine whether there were any correlations.
RESULTS: We found that the AD brain is capable of generating all macrophage-like responses. In addition, we found that early AD is distinct from late AD with respect to the inflammatory profiles expressed in the brain. Most interestingly, however, we found that the early AD samples were biased to one of two phenotypes, M1 or M2a.
CONCLUSION: Heterogeneity in the neuroinflammatory state of the early AD brain.

Entities:  

Mesh:

Year:  2013        PMID: 24021538     DOI: 10.1159/000354228

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  18 in total

Review 1.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

2.  Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microglia.

Authors:  D G Walker; A M Whetzel; L-F Lue
Journal:  Neuroscience       Date:  2014-10-05       Impact factor: 3.590

3.  Role of orexin A signaling in dietary palmitic acid-activated microglial cells.

Authors:  Cayla M Duffy; Ce Yuan; Lauren E Wisdorf; Charles J Billington; Catherine M Kotz; Joshua P Nixon; Tammy A Butterick
Journal:  Neurosci Lett       Date:  2015-08-22       Impact factor: 3.046

Review 4.  Microglia in the TBI brain: The good, the bad, and the dysregulated.

Authors:  David J Loane; Alok Kumar
Journal:  Exp Neurol       Date:  2015-09-03       Impact factor: 5.330

5.  Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.

Authors:  Yohannes Haile; Maryam Nakhaei-Nejad; Paul A Boakye; Glen Baker; Peter A Smith; Allan G Murray; Fabrizio Giuliani; Nadia Jahroudi
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

6.  [Effect of directive differentiation of microglia by SN50 on hypoxia-caused neurons injury in mice].

Authors:  Fangfang Han; Chunlong Liu; Changqing Yang; Yuanhua Sun
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-04-15

Review 7.  Multifactorial Etiology of Adolescent Nicotine Addiction: A Review of the Neurobiology of Nicotine Addiction and Its Implications for Smoking Cessation Pharmacotherapy.

Authors:  Supriya D Mahajan; Gregory G Homish; Amanda Quisenberry
Journal:  Front Public Health       Date:  2021-07-05

Review 8.  Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.

Authors:  Douglas G Walker; Lih-Fen Lue
Journal:  Alzheimers Res Ther       Date:  2015-08-19       Impact factor: 6.982

Review 9.  Neuroinflammation and M2 microglia: the good, the bad, and the inflamed.

Authors:  Jonathan D Cherry; John A Olschowka; M Kerry O'Banion
Journal:  J Neuroinflammation       Date:  2014-06-03       Impact factor: 8.322

Review 10.  Calcineurin and glial signaling: neuroinflammation and beyond.

Authors:  Jennifer L Furman; Christopher M Norris
Journal:  J Neuroinflammation       Date:  2014-09-10       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.